After the completion of human genomic project, most human expressed genes have been identified, and full-length cDNA of these genes have become publicly available. In the emerging proteomics era, proteins act as the key players in the unveiling of these genes. In order to effectively decipher the mystery of these proteins, antibodies with their inherent sensitivity and specificity thus become the most versatile tools for providing one-to-one relationship with their target proteins.
Abnova offers a unique complete monoclonal antibody and protein experience for our customer that is different from traditional custom production companies and laboratories.
We maintain a streamlined monoclonal production facility with scalable capacity for up to 500 immunization per month, and a state-of-the-art specific pathogen free (SPF) facility, which has the breeding and holding capacity for 10,000+ mice. These facilities allow us to significantly bring down the cost of customized monoclonal antibody production. We have also incorporated numerous automation systems into our production line, which significantly increased our efficiency.
Wheat Germ In Vitro Protein Expression System:
We have a high throughput protein production system, which allows soluble expression of conformational correct protein either from full-length cDNA or specific domains.